Canadian best practice recommendations for the management of amyotrophic lateral sclerosis


  • Management of patients living with amyotrophic lateral sclerosis (ALS) requires specialized multidisciplinary holistic care.

  • Disease-modifying pharmacologic therapies to treat ALS include riluzole and edaravone.

  • Close attention to nutritional support and respiratory care is required for optimal care in ALS.

  • Multiple treatments are available to ease the symptoms of ALS.

  • Palliative care and caregiver support are important components of assisting patients along their journey with ALS.